Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection-Reference-Cited by-同舟云学术

Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection

Published:2022-12 Issue:12 Volume:3 Page:838-847.e3
ISSN:2666-6340
Container-title:Med
language:en
Short-container-title:Med

Author:

Planas Delphine^ORCID,Staropoli Isabelle,Porot Françoise,Guivel-Benhassine Florence,Handala Lynda,Prot Matthieu,Bolland William-Henry,Puech Julien,Péré Hélène,Veyer David,Sève Aymeric,Simon-Lorière Etienne,Bruel Timothée,Prazuck Thierry,Stefic Karl,Hocqueloux Laurent,Schwartz Olivier

Publisher

Elsevier BV

Subject

General Medicine

Reference44 articles.

1. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa;Viana;Nature,2022

2. COVID-19 will continue but the end of the pandemic is near;Murray;Lancet,2022

3. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant;Andrews;N. Engl. J. Med.,2022

4. Effect of mRNA vaccine boosters against SARS-CoV-2 omicron infection in Qatar;Abu-Raddad;N. Engl. J. Med.,2022

5. Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 omicron and Delta variants;Accorsi;JAMA,2022

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS‐CoV‐2 reinfection broadens the antibody responses and promotes the phenotypic differentiation of virus‐specific memory T cells in adolescents;Journal of Medical Virology;2024-08

2. Humoral and cellular immune responses following Omicron BA.2.2 breakthrough infection and Omicron BA.5 reinfection;iScience;2024-07

3. Long-term levels of protection of different types of immunity against the Omicron variant: a rapid literature review;Swiss Medical Weekly;2024-05-06

4. Impact of immune evasion, waning and boosting on dynamics of population mixing between a vaccinated majority and unvaccinated minority;PLOS ONE;2024-04-04

5. Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion;Nature Communications;2024-03-13